Publications (249) Publications in which a researcher has participated

2025

  1. Effects of Alzheimer’s disease plasma marker levels on multilayer centrality in healthy individuals

    Alzheimer's Research and Therapy , Vol. 17, Núm. 1

2024

  1. An Injectable Composite Co-Assembled Dehydropeptide-Based Magnetic/Plasmonic Lipogel for Multimodal Cancer Therapy

    Advanced Functional Materials, Vol. 34, Núm. 38

  2. Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol

    Frontiers in Psychiatry, Vol. 15

  3. Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia

    Schizophrenia Research, Vol. 270, pp. 260-272

  4. Clinical Manifestations

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 20, pp. e087070

  5. Functioning in schizophrenia: Recommendations of an expert panel

    Schizophrenia Research, Vol. 270, pp. 317-322

  6. Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain

    Neural Regeneration Research, Vol. 19, Núm. 8, pp. 1617-1677

  7. Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study

    Neurologia

  8. Increasing prevalence of self-harm, suicidal behavior and suicidal ideation throughout a three-year period in the context of COVID-19 pandemic in Spain

    Psychiatry Research, Vol. 339

  9. Longitudinal changes in the functional connectivity of individuals at risk of Alzheimer’s disease

    GeroScience, Vol. 46, Núm. 3, pp. 2989-3003

  10. Minimum spanning tree analysis of unimpaired individuals at risk of Alzheimer's disease

    Brain Communications, Vol. 6, Núm. 5

  11. Neurofilament light chain plasma levels in major depressive disorder: a brief research report

    Frontiers in Psychiatry, Vol. 15

  12. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

2023

  1. Anxiety and depression played a central role in the COVID-19 mental distress: A network analysis

    Journal of Affective Disorders, Vol. 338, pp. 384-392

  2. Cenobamate in real-life setting: final outcomes of an expanded access program

    35th International Epilepsy Congress, Dublin, IRELAND

  3. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions

    Psychiatry Research, Vol. 330

  4. Human Breast Milk microRNAs, Potential Players in the Regulation of Nervous System

    Nutrients, Vol. 15, Núm. 14

  5. MiRNA Differences Related to Treatment-Resistant Schizophrenia

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  6. Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

  7. Proteomic analysis of exosomes derived from human mature milk and colostrum of mothers with term, late preterm, or very preterm delivery

    Analytical Methods, Vol. 15, Núm. 37, pp. 4905-4917